National Institutes of Health Overview
- Investor Type
- Government
- Status
- Active
- Professionals
- 1
- Investments
- 1,475
- Portfolio
- 947
- Exits
- 190
National Institutes of Health General Information
Description
Founded in 1887, the National Institutes of Health is an investment firm headquartered in Bethesda, Maryland. The firm provides grants and venture capital to firms operating in the pharmaceuticals and biotechnology sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Government
Other Investor Types
Accelerator/Incubator
Primary Office
- 9000 Rockville Pike
- Bethesda, MD 20892
- United States
+1 (301) 000-0000
National Institutes of Health Investments (1,475)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Enspectra Health | 26-May-2021 | Grant | 000 | Diagnostic Equipment | Product Development | |
| 00000000 000000000 | 17-May-2021 | 00000 | 00000 | Drug Discovery | Generating Revenue | |
| 0000000 0000000000 | 11-May-2021 | 00000 | 00.000 | Drug Discovery | Clinical Trials - Phase 1 | |
| 000000000 00000000 | 04-May-2021 | 00000 | 000 | Drug Discovery | Clinical Trials - General | |
| 00000000000000000 | 22-Apr-2021 | 00000 | 0000 | Other Devices and Supplies | Generating Revenue | |
| 000000 00000000000 | 22-Apr-2021 | 00000 | 00.000 | Discovery Tools (Healthcare) | Generating Revenue | |
| 000000 000000000 0 | 19-Apr-2021 | 00000 00000 | 00.000 | Diagnostic Equipment | Generating Revenue | |
| 000000 | 06-Apr-2021 | 00000 | 000 | Surgical Devices | Generating Revenue | |
| Armonica Technologies | 29-Mar-2021 | Grant | 00000 | Biotechnology | Product In Beta Test | |
| Cellular Logistics | 16-Mar-2021 | Grant | 00000 | Biotechnology | Generating Revenue |
National Institutes of Health Exits (190)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| ieCrowd | 21-May-2021 | Out of Business | |
| 0000000000 | 17-May-2021 | 000000000000000000 | |
| 0000 000000000000 | 14-May-2021 | 000 | 000.00 |
| 000000 00000000000 | 28-Apr-2021 | 000000000000000000 | |
| 00000 0 0000000000 | 23-Apr-2021 | 000 00 00000000 | |
| 00000 00000000000 | 22-Apr-2021 | 000 | 0000 |
| 000000000 | 16-Apr-2021 | 000 | 00000 |
| 000000 (0000000000 | 01-Apr-2021 | 0000000000 | |
| Dignify Therapeutics | 24-Mar-2021 | Buyout/LBO | |
| Mesa Biotech | 26-Feb-2021 | Merger/Acquisition | 00000 |
National Institutes of Health Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialNational Institutes of Health Team (12)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Shabestari Shabestari | Partner | 0 | Bethesda, MD | ||
| James Anderson Ph.D | Director of the Division & Deputy Director for Program Coordination, Planning and Strategic Initiatives | 0 | Bethesda, MD | ||
| Ahmed Hasan | Medical Officer & Program Director, NHLBI | 0 | Bethesda, MD | ||
| Francis Collins Ph.D | Chief Director | 0 | Bethesda, MD | ||
| J.P. Kim | Program Manager & Extramural Data Sharing Policy Officer | 0 | Bethesda, MD |
National Institutes of Health Co-Investors (37)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| TEDCO | 2 |
|
|
||
| Citadel (Hedge Fund) | 0 |
|
|
||
| Eli Lilly | 0 | 0 |
|
|
|
| General Catalyst | 0 |
|
|
||
| Western Technology Investment | 0 |
|
|